Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Changes in Plasma Osmolality
Mean change from baseline in plasma osmolality (OSM) in the 4 treatment groups. A significant increase was observed in all of the tolvaptan dosing groups (p < 0.0005 for all tolvaptan groups vs. placebo at 4 h and later).
|
